Edoardo Marchesi

Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells

Valentina Zuco, Rosanna Supino, Sabina Carla Righetti et al. · Cancer Letters · 2002 · 521 citations

Tumor Biology, Oncogenic Agent, Medicine +9

Induction of resistance to the Abelson inhibitor STI571 in human leukemic cells through gene amplification

Philipp le Coutre, E. ̃Tassi, Marileila Varella‐Garcia et al. · Blood · 2000 · 487 citations

In Vivo Eradication of Human BCR/ABL-Positive Leukemia Cells With an ABL Kinase Inhibitor

Philipp le Coutre, Luca Mologni, Loredana Cleris et al. · JNCI Journal of the National Cancer Institute · 1999 · 377 citations · Full text

<i>In vitro</i> and <i>In vivo</i> Activity of SKI-606, a Novel Src-Abl Inhibitor, against Imatinib-Resistant Bcr-Abl+ Neoplastic Cells

Miriam Puttini, Addolorata Maria Luce Coluccia, Frank Boschelli et al. · Cancer Research · 2006 · 368 citations

Hematological Malignancy, Cell Signaling, Ski-606 Activity +13

Inhibition of the ABL Kinase Activity Blocks the Proliferation of BCR/ABL+Leukemic Cells and Induces Apoptosis

Carlo Gambacorti‐Passerini, Philipp le Coutre, Luca Mologni et al. · Blood Cells Molecules and Diseases · 1997 · 317 citations

Hematological Malignancy, Cancer Research, Mixed-phenotype Acute Leukemia +9